Jelena Begovic
Bilateral Meetings
- (11:30 - 15:00)
agriculture
DEVELOPMENT OF INNOVATIVE PROBIOTICS FOR ANIMALS
Introduction of beneficial microorganisms through the food has a positive effect on the health of humans and animals. While the use of probiotics for humans is widespread, the use of probiotics in livestock and accompanied animals is still negligible. The increased interest in the use of probiotics for animals was driven by tighter European regulations on the use of antibiotics in livestock production. Therefore, probiotics are considered adequate alternative when it comes to intestinal infections in domestic animals, especially in the period from birth to weaning. In addition, recent studies reported that use of probiotics can be useful for prevention and treatment of various non-communicable diseases. Therefore, Laboratory for Molecular Microbiology, Institute of Molecular Genetics and Genetic Engineering (LMM-IMGGE), University of Belgrade, is dedicated to development of novel probiotics for animals based on natural isolates of lactic acid bacteria. The ultimate goal is production of innovative standardized probiotics for animals in the prevention and treatment of various diseases in animals. We look for partners in the field of livestock production and small veterinary practice, as well as for distributors for innovative probiotics from all countries in the Balkan region.
- License agreement
- Technical co-operation
- Investment/Financing
- Sales / Distribution
- Manufacturing agreement
COMPREHENSIVE GENETIC TESTING OF BEEF CATTLE
Our aim is to introduce new technology in DNA sequencing in the process of animal breeding, which would include an analysis of a large number of genetic markers related to the origin (paternity), hereditary diseases, quality of meat and milk and fertility. This innovative approach will accelerate the program of positive selection in cattle breeding which would lead to the overall improvement of the genetic potential of the cattle population in the region, improvement of breeding programs, rapid development of animal husbandry and development of commercial capacities related to milk and meat production. We look for veterinarians and stockbreeders and cattle breeding organizations from all countries in the Balkan region in order to apply for common projects (Cross-border calls, Danube initiative etc).
- Technical co-operation
- Investment/Financing
DEVELOPMENT OF NOVEL ANTIMICROBIAL AGENTS, BIOCATALYST AND BIOPOLYMERS
Microorganisms have been unmatched source of compounds for drug discovery, as well as enzymes for biocatalytic applications, and they continue to deliver new scaffolds and leads to the fields of medical and industrial biotechnology. The therapeutic areas of infectious diseases and oncology have benefited from abundant scaffold diversity in microbial natural products, as they have continued to enter clinical trials or to provide leads for compounds that have entered clinical trials. The use of bacteria and/or their enzymes in industry, besides beneficial economical aspects, could also improve the sustainability of our industry and our environment. Biocatalysis offers beneficial solutions to the problems of synthesis of fine chemical in an efficient and environmentally benign manner. The characteristics of bio-based polymers and their ability to achieve improved functionalities that surpass those of fossil-based ones, offers opportunities to expand market applications for biopolymers far beyond the current state-of-art. Our Laboratory for Microbial Molecular Genetics and Ecology, IMGGI is continuously discovering and developing new small molecule drug candidates, biocatalysts and bacterial biopolymers with advanced functionalities from microbial resources for high performance applications. We offer to develop and deliver novel bioactive compounds, biocatalysts and biomaterials originating from in-house laboratory collection, as well as other microbial resources with the aim to improve people`s lifestyle and environment.
Antimicrobial agents – novel agents with new structures that overcome resistance and prevent formation or disrupt preformed biofilms.
Novel biocatalysts – development of novel biosynthetic routs which overcome problems in synthesis of fine chemicals (chemical or pharmaceutical industry).
Natural polymers – discovery of novel biomaterials from bacteria and functionalization of bioplastics and nanocellulose.
- Technical co-operation
- Other
- Investment/Financing
- Other